I. Nachamkin et al., UTILIZATION OF TESTS FOR LYME-DISEASE ANTIBODY AT A UNIVERSITY HOSPITAL, Clinical and diagnostic laboratory immunology, 3(3), 1996, pp. 287-289
We performed a retrospective study on patients who had a positive scre
ening antibody test result for antibody to Borrelia burgdorferi to det
ermine the clinical indicators used by physicians to order this test.
Eighty-two evaluable patients who were screen positive (indirect enzym
e-linked immunosorbent assay) between August 1991 and March 1993 were
included. Additional tests, isotype-specific capture immunoglobulin en
zyme immunoassay and Western blot (immunoblot) analysis (immunoglobuli
n G), were performed on positive samples. Of 82 patients with a positi
ve screening test result, 54 (66%) had no serologic evidence of Lyme d
isease on the basis of additional testing (positive predictive value,
34%). Only 28 of 82 patients (34%) had clinical indicators suggestive
of Lyme disease. Antibody screening tests may provide misleading infor
mation if they are not accompanied by more specific assays. Inappropri
ate testing of patients without indications of Lyme disease is frequen
tly performed, and the ordering practices of physicians should be reas
sessed.